Jove
Visualize
Contact Us

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Master Transcription Regulators02:23

Master Transcription Regulators

6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Mesenchymal-epithelial Transition Factor Amplification Correlates With Adverse Pathological Features And Poor Clinical Outcome In Colorectal Cancer.
  1. Home
  2. Mesenchymal-epithelial Transition Factor Amplification Correlates With Adverse Pathological Features And Poor Clinical Outcome In Colorectal Cancer.

Related Experiment Video

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

35.8K

Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor

Qiu-Xiao Yu1, Ping-Ying Fu1, Chi Zhang1

  • 1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, Guangdong Province, China.

World Journal of Gastrointestinal Surgery
|May 31, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Polysomy-induced MET amplification, observed in 14.4% of colorectal cancer (CRC) cases, is linked to worse pathology and prognosis. Immunohistochemistry (IHC) is not a reliable screening tool for MET amplification.

Keywords:
AmplificationColorectal cancerFluorescence in situ hybridizationMETPathological featuresPrognosis

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K

Related Experiment Videos

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

35.8K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
  • The MET gene plays a role in tumor biology and is a potential therapeutic target.
  • Limited data exist on MET amplification in CRC, necessitating further investigation.

Purpose of the Study:

  • To investigate the pathological significance of MET amplification in colorectal cancer.
  • To evaluate MET amplification as a prognostic marker in CRC.
  • To propose a feasible screening strategy for MET amplification in CRC.

Main Methods:

  • Analysis of 205 newly diagnosed CRC patients without prior therapy.
  • Assessment of MET amplification using fluorescence in situ hybridization (FISH).
  • Evaluation of c-MET protein expression via immunohistochemistry (IHC).
  • Correlation analysis of MET aberration with pathological features and survival outcomes (PFS).
  • Main Results:

    • Polysomy-induced MET amplification detected in 14.4% of CRC cases; focal amplification was rare.
    • MET amplification correlated with increased lymph node metastasis and higher tumor budding grade.
    • Patients with MET amplification showed significantly poorer two-year progression-free survival (PFS).
    • IHC showed variable c-MET expression but poor correlation with MET amplification status.

    Conclusions:

    • Focal MET amplification is uncommon in CRC.
    • Polysomy-induced MET amplification is associated with adverse pathological features and poor prognosis in CRC.
    • IHC is not a suitable method for screening MET amplification in CRC.